CompletedNCT02566356
Oxytocin, Social Behavior and Brain Responses in Recent-Onset Schizophrenia
About this title
Read the official source —Medication studyAges 18–50United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- San Francisco and 1 more locationSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateSeptember 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 59
- Sponsor
- University of California, San Francisco
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- EARLY Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT02566356
- Official title
Show the full official title
Mechanisms and Effects of Oxytocin on Social Cognition in Schizophrenia - fMRI
Get this study by email
Recruitment & locations
CompletedSan Francisco
Questions about this study
Who is behind this study?
The study sponsor is University of California, San Francisco, a university.
Did this study involve medication?
Yes. The study involved medication, including Oxytocin and Saline Nasal Spray.
Who was this study for?
Listed age limits: 18 years to 50 years.
Want to explore more studies?
Explore studiesRelated studies
Paliperidone Injections Compared With Oral Medication for Schizophrenia
18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in Participants With Schizophrenia